Crossmark

‘Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings

Crossref DOI link: https://doi.org/10.14283/jpad.2023.50

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dickson, S.P.

Wessels, Alette M.

Dowsett, S.A.

Mallinckrodt, C.

Sparks, J.D.

Chatterjee, S.

Hendrix, S.
License Information

Text and Data Mining valid from 2023-09-01

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2023-05-03
More Information

This article is maintained by: Elsevier

Article Title: ‘Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2023.50

Content Type: article

Copyright: Copyright © 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS